AbL Diagnostics SA
PAR:ABLD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.4
9.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
AbL Diagnostics SA
AbL Diagnostics SA
Total Liabilities & Equity
AbL Diagnostics SA
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
AbL Diagnostics SA
PAR:ABLD
|
Total Liabilities & Equity
€14.9m
|
CAGR 3-Years
84%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
Rexel SA
PAR:RXL
|
Total Liabilities & Equity
€14.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
3%
|
|
|
Jacquet Metals SA
PAR:JCQ
|
Total Liabilities & Equity
€1.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Thermador Groupe SA
PAR:THEP
|
Total Liabilities & Equity
€522m
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
|
Herige SA
PAR:ALHRG
|
Total Liabilities & Equity
€490.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
|
Gold by Gold SA
PAR:ALGLD
|
Total Liabilities & Equity
€6.8m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
AbL Diagnostics SA
Glance View
ABL Diagnostics SA engages in owning and renting railcars for the rail freight transportation. The company is headquartered in Suresnes, Ile-De-France. The firm also provides Commercial and Industrial Machinery and Equipment Rental and Leasing services.
See Also
What is AbL Diagnostics SA's Total Liabilities & Equity?
Total Liabilities & Equity
14.9m
EUR
Based on the financial report for Dec 31, 2023, AbL Diagnostics SA's Total Liabilities & Equity amounts to 14.9m EUR.
What is AbL Diagnostics SA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
10%
Over the last year, the Total Liabilities & Equity growth was -3%. The average annual Total Liabilities & Equity growth rates for AbL Diagnostics SA have been 84% over the past three years , 14% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
